Maryland Pearl Tox Screen

I hope everyone suscribes to the UMEM pearls.

Title: Drug Abuse Screens
Author: Kishan Kapadia
[Click to email author]


Performance Characteristics of Common Drug Abuse Screening Immunoassays
Drug/Class
Detection Interval (***)
Comments
Amphetamines
1-2 days (2-4 days)
Decongestants, ephedrine,l-methamphetamine, selegilene & bupropion metabolites may give False (+) results; MDA & MDMA are variably detected
Barbiturates
2-4 days
Phenobarbital may be detected for up to 4 weeks
Benzodiazepines
1-30 days
Benzos vary in reactivityand potency; False (+) results may be seen with oxaprozin
Cannabinoids
1-3 days (>1 month)
Screening assays detect inactive and active cannabinoids; Confirmatory assays detects inactive metabolite THCA (tetrahydrocannabinoic acid)
Cocaine 
2 days (1 week)
Screening & confirmatory assays detect inactive metabolite BE (benzoylecgonine); False (+) results are unlikely
Opiates
1-2 days; 2-4 days (<1 week)
Semisynthetic opiates derived from morphine show variable cross-reactivity; Fully synthetic opioids (e.g., fentanyl, meperidine, methadone, propoxyphene, tramadol) have minimal cross reactivity; Quinolone may cross-react
Methadone
1-4 days
Doxylamine may cross-react
Phencyclidine
4-7 days (>1 month)
Dextromethorphan, diphenhydramine, ketamine, & venlafaxine may cross react
Propoxyphene
3-10 days
Duration of positivity depends on cross reactivity of metabolite norpropoxyphene
(***)Values are after typical use; values in parentheses are after heavy or prolonged use.
References

Adapted from Goldfrank’s Toxicologic Emergencies, 9th ed; Table 6-10.